← Return to Is Cemiplimab, an immunotherapy, effective for basal cell carcinoma?

Discussion
Comment receiving replies
Profile picture for martajean @martajean

@grammato3 Thank you for your interest. Since the BCC tumor was located in the orbital behind my left eye, targeted radiation or even proton therapy would definitely destroy the lacrimal gland, which would make life with that eye very uncomfortable. Traditional radiation might also damage the cornea of the eye and could result in vision loss. They cannot guarantee that my eye would survive the treatments: 5 treatments per week for 6 to 7 weeks. For now, I'll be having surgery in a few months to repair damage caused by the tumor. If I need to resume chemo thereafter, I'm looking into immunotherapy, since my body is no longer tolerating the Erivedge, with which I had a seven-month run that destroyed the tumor. Of course, there could still be microscopic BCC present, which is why the surgeon will also biopsy the tissue in the location where the tumor was located.

Jump to this post


Replies to "@grammato3 Thank you for your interest. Since the BCC tumor was located in the orbital behind..."

@martajean: thank you for that explanation. When the lacrimal gland is involved it definitely can complicate matters. I’m wondering if in a case such as this if combination immunotherapy of Nivolumab/Pembrolizumab would be considered?